Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy

Hepatitis C virus (HCV) is a leading cause of liver disease worldwide. Although several HCV protease/polymerase inhibitors were recently approved by U.S. FDA, the combination of antivirals targeting multiple processes of HCV lifecycle would optimize anti-HCV therapy and against potential drug-resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Lin, Chen, Jizheng, Wang, Yaxin, Yang, Yuting, Qing, Jie, Rao, Zihe, Chen, Xinwen, Lou, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Higher Education Press 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338621/
https://www.ncbi.nlm.nih.gov/pubmed/29542010
http://dx.doi.org/10.1007/s13238-018-0521-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338621/
https://www.ncbi.nlm.nih.gov/pubmed/29542010
http://dx.doi.org/10.1007/s13238-018-0521-z

Ejemplares similares